SCHEMBL365040

SCHEMBL365040

CN(C)CCOC(=O)c1c2ccccc2n2cc(C(=O)CCN(C)C)ccc12

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
TDP1 Q9NUW8 2/20 0.43
MAPT P10636 3/20 0.43
RAD52 P43351 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PHLPP2 Q6ZVD8 1/20 0.41
POLB P06746 2/20 0.41
EGFR P00533 2/20 0.40
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
STAT6 P42226 1/20 0.38
HSD17B10 Q99714 1/20 0.38
THRA P10827 2/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL364775 0.94 ALDH1A1 (0.47) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL364768 0.93 ALDH1A1 (0.46) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL366312 0.91 ALDH1A1 (0.52) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL364914 0.91 ALDH1A1 (0.47) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL365804 0.91 ALDH1A1 (0.45) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL364337 0.90 ALDH1A1 (0.44) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL365411 0.89 ALDH1A1 (0.53) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL365388 0.88 ALDH1A1 (0.49) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL366410 0.88 ALDH1A1 (0.45) ALDH1A1TDP1MAPTRAD52MEN1
SCHEMBL366302 0.86 ALDH1A1 (0.47) ALDH1A1TDP1MAPTRAD52MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed